Cell and Organ Transplantology. 2017; 5(1):50-55.
DOI: 10.22494/COT.V5I1.68
Effect of fetal cerebellum tissue transplantation on the spasticity and chronic pain syndrome after spinal cord injury in rats
Medvediev V. V.1, Senchyk Yu. Yu.2, Tatarchuk M. M.3, Draguntsova N. G.3, Dychko S. M.3, Tsymbaliuk V. I.3
1Bogomoletz National Medical University, Kyiv, Ukraine
2Kyiv city clinical emergency hospital, Kyiv, Ukraine
3A. P. Romodanov State Institute of Neurosurgery NAMS Ukraine, Kyiv, Ukraine
Abstract
The syndromes of spasticity and chronic pain are diagnosed in the majority of patients in different periods of recovering from spinal injury. Current synthetic or semi-synthetic matrixes, tissue and cell transplants, which are used in the treatment of spinal cord injuries, can affect the development of the syndrome of spasticity and chronic pain.
Objective. To examine the effect of fetal cerebellum tissue transplantation (FCTT) on the course of the spasticity and chronic pain syndrome after experimental spinal cord injury.
Materials and methods. Animals – albino outbred male rats (5.5 months, 300 grams, inbred line, the original strain – Wistar); main experimental groups: 1 – spinal cord injury only (n = 16), 2 – spinal cord injury + immediate homotopical implantation of a fragment of the fetal cerebellum tissue (n = 15). Model of injury – left-side spinal cord hemisection at Т11 level; verification of spasticity – by Ashworth scale and electroneuromyography, severe pain syndrome – by autophagy.
Results. FCTT does not affect the frequency of severe neuropathic pain syndrome, is accompanied by early (1st week) debut of spasticity signs, significantly increases the level of spasticity (1st-3rd weeks), which is most likely due to glutamatergic effect of descendants of immature transplant cells – cerebellar granular neurons precursors. The maximum increase of the spasticity in the case of FCTT was observed at the 3rd week, in the control group – within the 1st and 4th weeks; from the 4th week after FCTT till the end of the experiment stabilization of spasticity rate in the range of 1.8-2.1 points was observed, which is probably due to the autoimmune motoneurons loss in the perifocal area. At the 24th week the level of spasticity in the case of FCTT succumbed to 2.1 ± 0.3 points, in the control group – 2.6 ± 0.4 Ashworth’s points (p > 0.05).
Conclusion. Immediate fetal cerebellum tissue transplantation in rats with spinal cord injury causes early pro-spastic effect, in the long term – stabilizes spasticity level.
Key words: spinal cord injury; fetal cerebellum tissue transplantation; motor function recovery; posttraumatic spasticity syndrome; chronic pain syndrome
Full Text PDF (eng) Full Text PDF (ua)
1. Lee BB, Cripps RA, Fitzharris М, et al. The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate. Spinal Cord. 2014; 52(2): 110-16. https://doi.org/10.1038/sc.2012.158 PMid:23439068 |
||||
2. Malhotra S, Pandyan AD, Day CR, et al. Spasticity, an impairment that is poorly defined and poorly measured. Clin Rehabil. 2009; 23(7): 651-58. https://doi.org/10.1177/0269215508101747 PMid:19470550 |
||||
3. Hwang M, Zebracki K, Chlan KM, et al. Longitudinal changes in medical complications in adults with pediatric-onset spinal cord injury. J Spinal Cord Med. 2014; 37(2): 171-78. https://doi.org/10.1179/2045772313Y.0000000150 PMid:24090490 PMCid:PMC4066425 |
||||
4. Christensen MD, Hulsebosch C. Сhronic central pain after spinal cord injury. J Neurotrauma. 1997; 14(8): 517-37. https://doi.org/10.1089/neu.1997.14.517 PMid:9300563 |
||||
5. Finnerup NB, Norrbrink C, Trok K, et al. Phenotypes and predictors of pain following traumatic spinal cord injury: a prospective study. J Pain. 2014; 15(1): 40-48. https://doi.org/10.1016/j.jpain.2013.09.008 PMid:24268112 |
||||
6. Wu J, Sun T, Ye C, et al. Clinical observation of fetal olfactory ensheathing glia transplantation (OEGT) in patients with complete chronic spinal cord injury. Cell Transplant. 2012; 21(1): 33-37. https://doi.org/10.3727/096368912X633743 PMid:22507678 |
||||
7. Hofstetter CP, Holmström NAV, Lilja JA, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nature Neurosci. 2005; 8(3): 346-53. https://doi.org/10.1038/nn1405 PMid:15711542 |
||||
8. Macias MY, Syring MB, Pizzi MA, et al. Pain with no gain: Allodynia following neural stem cell transplantation in spinal cord injury. Exp Neurology. 2006; 201: 335-48. https://doi.org/10.1016/j.expneurol.2006.04.035 PMid:16839548 |
||||
9. Piltti K, Salazar D, Uchida N, et al. Safety of human neural stem cell transplantation in chronic spinal cord injury. Stem Cell Transl Med. 2013; 2: 961-974. Available: http://dx.doi.org/10.5966/sctm.2013-0064 https://doi.org/10.5966/sctm.2013-0064 |
||||
10. Roh DH, Seo MS, Choi HS, et al. Transplantation of human umbilical cord blood or amniotic epithelial stem cells alleviates mechanical allodynia after spinal cord injury in rats. Cell Transplant. 2013; 22(9): 1577-90. https://doi.org/10.3727/096368912X659907 PMid:23294734 |
||||
11. Luo Y, Zou Y, Yang L, et al. Transplantation of NSCs with OECs alleviates neuropathic pain associated with NGF downregulation in rats following spinal cord injury. Neurosci Lett. 2013; 549: 103-108. Available: http://dx.doi.org/10.1016/j.neulet.2013.06.005 https://doi.org/10.1016/j.neulet.2013.06.005 |
||||
12. Yao ZG, Sun XL, Li P, et al. Neural stem cells transplantation alleviate the hyperalgesia of spinal cord injured (SCI) associated with down-regulation of BDNF. Int J Clin Exp Med. 2015; 8(1): 404-412. Available: www.ijcem.com/ISSN:1940-5901/IJCEM0003074 | ||||
13. Watanabe S, Uchida K, Nakajima H, et al. Early transplantation of mesenchymal stem cells after spinal cord injury relieves pain hypersensitivity through suppression of pain-related signaling cascades and reduced inflammatory cell recruitment. Stem Cells. 2015; 33(6): 1902-1914. https://doi.org/10.1002/stem.2006 PMid:25809552 |
||||
14. Yousefifard M, Nasirinezhad F, Manaheji HS, et al. Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. Stem Cell Res Ther. 2016; 7(36): 1-14. https://doi.org/10.1186/s13287-016-0295-2 |
||||
15. Hua R, Li P, Wang X, et al. Evaluation of somatosensory evoked potential and pain rating index in a patient with spinal cord injury accepted cell therapy. Pain Physician. 2016; 19: 659-666. | ||||
16. Tsymbaliuk VI, Medvediev VV. Spinnoy mozg. Elegiya nadezhdy: monografiya [Spinal cord. Elegy of hope: a monograph]. Vinnitsa: Nova Kniga – Vinnitsa: New Book, 2010. 944 p. [in Russian] | ||||
17. Marzban H, Del Bigio MR, Alizadeh J, et al. Cellular commitment in the developing cerebellum. Front Cell Neurosci. 2015; 8: 1-26. Available: http://journal.frontiersin.org/article/10.3389/fncel.2014.00450/full https://doi.org/10.3389/fncel.2014.00450 PMid:25628535 PMCid:PMC4290586 |
||||
18. Kumar M, Csaba Z, Peineau S, et al. Endogenous cerebellar neurogenesis in adult mice with progressive ataxia. Ann Clin Transl Neurol. 2014; 1(12): 968-81. https://doi.org/10.1002/acn3.137 PMid:25574472 PMCid:PMC4284123 |
||||
19. Chang JC, Leung M, Gokozan HN, et al. Mitotic events in cerebellar granule progenitor cells that expand cerebellar surface area are critical for normal cerebellar cortical lamination in mice. J Neuropathol Exp Neurol. 2015; 74(3): 261-72. https://doi.org/10.1097/NEN.0000000000000171 PMid:25668568 PMCid:PMC4333719 |
||||
20. Ma M, Wu W, Li Q, et al. N-myc is a key switch regulating the proliferation cycle of postnatal cerebellar granule cell progenitors. Sci Rep. 2015; 5: 1-13. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523855/ https://doi.org/10.1038/srep12740 |
||||
21. Leffler SR, Legué E, Aristizábal O,•et al. A mathematical model of granule cell generation during mouse cerebellum development. Bull Math Biol. 2016; 78(5): 859-78. https://doi.org/10.1007/s11538-016-0163-3 PMid:27125657 PMCid:PMC4911999 |
||||
22. Zhu T, Tang H, Shen Y, et al. Transplantation of human induced cerebellar granular-like cells improves motor functions in a novel mouse model of cerebellar ataxia. Am J Transl Res. 2016; 8(2): 705-18. PMid:27158363 PMCid:PMC4846920 |
||||
24. Medvediev VV, Senchyk YuYu, Draguntsova NG, Dychko SM, Tsymbaliuk VI. Effect of fetal cerebellar tissue transplantation on the restoration of hind limb locomotor function in rats with spinal cord injury. Cell and Organ Transplantology. 2016; 4(2):175-180. doi:10.22494/COT.V4I2.57 https://doi.org/10.22494/cot.v4i2.57 |
||||
25. Dong HW, Wang LH, Zhang M, et al. Han Decreased dynorphin A (1–17) in the spinal cord of spastic rats after the compressive injury. Brain Res Bull. 2005; 67(3): 189-195. https://doi.org/10.1016/j.brainresbull.2005.06.026 PMid:16144654 |
||||
26. Hahm SC, Yoon YW, Kim J. High-frequency transcutaneous electrical nerve stimulation alleviates spasticity after spinal contusion by inhibiting activated microglia in rats. Neurorehabil Neural Repair. 2015; 29(4): 370-381. https://doi.org/10.1177/1545968314545172 PMid:25122586 |
||||
27. Palmieri RM, Ingersoll CD, Hoffman MA. The hoffmann reflex: methodologic considerations and applications for use in sports medicine and athletic training research. J Athl Train. 2004; 39(3): 268-277. PMid:16558683 PMCid:PMC522151 |
||||
28. Yates C, Garrison K, Reese NB, et al. Novel mechanism for hyper-reflexia and spasticity. Prog Brain Res. 2011; 188: 167-180. https://doi.org/10.1016/B978-0-444-53825-3.00016-4 PMid:21333809 PMCid:PMC3646581 |
||||
29. Tan AM, Chakrabarty S, Kimura H, et al. Selective corticospinal tract injury in the rat induces primary afferent fiber sprouting in the spinal cord and hyperreflexia. J Neurosci. 2012; 32(37): 12896-908. https://doi.org/10.1523/JNEUROSCI.6451-11.2012 PMid:22973013 PMCid:PMC3499628 |
||||
30. Bandaru SP, Liu S, Waxman SG, et al. Dendritic spine dysgenesis contributes to hyperreflexia after spinal cord injury. J Neurophysiol. 2015; 113:1598-615. https://doi.org/10.1152/jn.00566.2014 PMid:25505110 PMCid:PMC4346729 |
||||
31. Barakat MI, Elhady W, Gouda M, et al. Surgical management of intractable spasticity. Eur Spine J. 2016; 25(3): 928-935. https://doi.org/10.1007/s00586-015-4326-y PMid:26667812 |
||||
33. Christensen MD, Everhart AW, Pickelman JT, et al. Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain. 1996; 68(1): 97-107. https://doi.org/10.1016/S0304-3959(96)03224-1 |
||||
34. Sharp KG, Dickson AR, Marchenko SA, et al. Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation. Exp Neurol. 2012; 235(1): 345-56. https://doi.org/10.1016/j.expneurol.2012.02.016 PMid:22414309 PMCid:PMC3437931 |
||||
35. Hashimoto M, Hibi M. Development and evolution of cerebellar neural circuits. Dev Growth Differ. 2012; 54(3): 373-89. https://doi.org/10.1111/j.1440-169X.2012.01348.x PMid:22524607 |
||||
36. Hoshino M. Neuronal subtype specification in the cerebellum and dorsal hindbrain. Dev Growth Differ. 2012; 54(3): 317-26. https://doi.org/10.1111/j.1440-169X.2012.01330.x PMid:22404503 |
||||
37. Jankowski J, Miething A, Schilling K, et al. Cell death as a regulator of cerebellar histogenesis and compartmentation. Cerebellum. 2011; 10: 373-92. https://doi.org/10.1007/s12311-010-0222-5 PMid:20941559 |
||||
39. Casella GTB, Marcillo A, Bunge MB, et al. New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord. Exp Neurol. 2002; 173(1): 63-76. https://doi.org/10.1006/exnr.2001.7827 PMid:11771939 |
||||
40. Garcia E, Aguilar-Cevallos J, Silva-Garcia R, et al. Cytokine and growth factor activation in vivo and in vitro after spinal cord injury. Mediators Inflamm. 2016; 2016: 1–21. Available: https://www.hindawi.com/journals/mi/2016/9476020 | ||||
41. Kjell J, Olson L. Rat models of spinal cord injury: from pathology to potential therapies. Dis Model Mech. 2016; 9(10): 1125-137. https://doi.org/10.1242/dmm.025833 PMid:27736748 PMCid:PMC5087825 |
||||
42. Le Blon D, Hoornaert C, Detrez JR, et al. Immune remodelling of stromal cell grafts in the central nervous system: therapeutic inflammation or (harmless) side-effect? J Tissue Eng Regen Med. 2016; doi: 10.1002/term.2188. [Epub ahead of print]. https://doi.org/10.1002/term.2188 |
||||
43. Pajer K, Feichtinger G, Márton G, et al. Cytokine signaling by grafted neuroectodermal stem cells rescues motoneurons destined to die. Exp Neurol. 2014; 261:180-189. https://doi.org/10.1016/j.expneurol.2014.05.026 PMid:24907401 |
||||
44. Centonze D. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. Eur Neurol. 2014; 72(l): 6-8. https://doi.org/10.1159/000367615 PMid:25278116 |
||||
45. Kapadia M, Sakic B. Autoimmune and inflammatory mechanisms of CNS damage. Prog Neurobiol. 2011; 95(3): 301-33. https://doi.org/10.1016/j.pneurobio.2011.08.008 PMid:21889967 |
||||
46. Levite M. Glutamate receptor antibodies in neurological diseases. J Neural Transm. 2014; 121(8): 1029-75. https://doi.org/10.1007/s00702-014-1193-3 PMid:25081016 |
||||
47. Bakpa OD, Reuber M, Irani SR. Antibody associated epilepsies: clinical features, evidence for immunotherapies and future research questions. Seizure. 2016; 41: 26-41. https://doi.org/10.1016/j.seizure.2016.07.002 PMid:27450643 PMCid:PMC5042290 |
||||
48. Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017; 97(2): 839-87. https://doi.org/10.1152/physrev.00010.2016 PMid:28298428 |
||||
49. D’Amico JM, Condliffe EG, Martins KJB, et al. Recovery of neuronal and network excitability after spinal cord injury and implications for spasticity. Front Int Neurosci. 2014; 8: 1-24. Available: http://journal.frontiersin.org/article/10.3389/fnint.2014.00036/full | ||||
50. Crowe MJ, Bresnahan JC, Shuman SL, et al. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med. 1997; 3(1): 73-76. https://doi.org/10.1038/nm0197-73 PMid:8986744 |
||||
51. Liu XZ, Xu XM, Hu R, et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci. 1997; 17: 5395-406. PMid:9204923 |
||||
52. Kim P, Haisa T, Kawamoto T, et al. Delayed myelopathy induced by chronic compression in the rat spinal cord. Ann Neurol. 2004; 55(4): 503-11. https://doi.org/10.1002/ana.20018 PMid:15048889 |
||||
53. Moghaddam A, Child C, Bruckner T, et al. Posttraumatic inflammation as a key to neuroregeneration after traumatic spinal cord injury. Int J Mol Sci. 2015; 16(4): 7900-916. https://doi.org/10.3390/ijms16047900 PMid:25860946 PMCid:PMC4425057 |
||||
54. Shabbir A, Bianchetti E, Cargonja R, et al. Role of HSP70 in motoneuron survival after excitotoxic stress in a rat spinal cord injury model in vitro. Eur J Neurosci. 2015; 42(12): 3054-65. https://doi.org/10.1111/ejn.13108 PMid:26490753 |
||||
55. Pajer K, Feichtinger G, Márton G, et al. Cytokine signaling by grafted neuroectodermal stem cells rescues motoneurons destined to die. Exp Neurol. 2014; 261: 180-89. https://doi.org/10.1016/j.expneurol.2014.05.026 PMid:24907401 |
Medvediev VV, Senchyk YuYu, Tatarchuk MM, Draguntsova NG, Dychko SM, Tsymbaliuk VI. Effect of fetal cerebellum tissue transplantation on the spasticity and chronic pain syndrome after spinal cord injury in rats. Cell and Organ Transplantology. 2017; 5(1):50-55. doi:10.22494/cot.v5i1.68
Is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.